Innovative Drug R&D in China

As Chinese pharmaceutical industry is rapidly rising, a growing number of Chinese drug companies and organizations (including pharma and biotech companies, research institutions and even outsourcing service providers) pay attention to innovative drug R&D. Their attempts are also encouraged by Chinese government who promise to provide financial support and further fueled by the growing abundance of venture capitals that are gradually becoming readily available to Chinese companies. However, to a large extent, the innovative drug R&D activities in Chinese companies still remain a myth to many companies outside China, including the scope and scale of their research, current state of their research capability and development stage of their product pipelines, etc.

To reveal the real state of the innovative drug R&D in China, we conducted a broad and in-depth investigation on the innovative drug R&D activities in China. This report summarized our latest research results on this subject.

The report is composed of four chapters and supported with 53 tables, 18 figures and 12 case studies. Each chapter focuses on one area and provides detail and in-depth description and analysis.

The sole source of its kind currently available on market, this report is a must-read book to all those professionals and organizations that are interested in learning how the innovative drug R&D in China is currently going and will likely develop in the future.